Biosimilars Canada is a national association representing the biosimilar medicines industry in Canada. We provide leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines, and advocate for policies that support their timely approval, reimbursement, market acceptance and expanded use.
Learn more about biosimilars and their benefits for patients and healthcare systems.
Article from The Center for Biosimilars of the covering the Biosimilars Canada Board Chair and Vice-Chair announcement, and key developments in the Canadian biosimilars landscape.
Anar Dossa, Director of Pharmacy Services at Pacific Blue Cross, shares the private insurer’s success and savings with biosimilar switching and future plans in this interview with the Not So Different podcast.